People: Adamas Pharmaceuticals Inc (ADMS.OQ)
Dr. Gregory T. Went, Ph.D., serves as Chairman of the Board, Chief Executive Officer, Co-Founder of Adamas Pharmaceuticals, Inc. Previously, Dr. Went co-founded CuraGen Corporation in 1992, where he served as an Executive Vice President and director from 1996 to 1999. Dr. Went also has served as a director of Angelica Therapeutics, Inc., a biotechnology company, since 2006. Dr. Went holds a Ph.D. in Chemical Engineering from the University of California, Berkeley and a B.S. in Chemical Engineering from Carnegie Mellon University. We believe Dr. Went’s extensive knowledge of our company, the pharmaceutical industry, and our competitors qualifies him to serve on our Board of Directors.
|Total Annual Compensation, USD||810,200|
|Restricted Stock Award, USD||529,238|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||2,019,680|
|Fiscal Year Total, USD||3,359,120|